Danel (Adir Yeoshua) Ltd (TLV:DANE)
50,790
0.00 (0.00%)
Sep 30, 2025, 5:24 PM IDT
Danel (Adir Yeoshua) Market Cap
Danel (Adir Yeoshua) has a market cap or net worth of 3.10 billion as of October 3, 2025. Its market cap has increased by 56.90% in one year.
Market Cap
3.10B
Enterprise Value
3.20B
Revenue
2.84B
Ranking
n/a
PE Ratio
128.65
Stock Price
50,790.00
Market Cap Chart
Since November 3, 2008, Danel (Adir Yeoshua)'s market cap has increased from 59.69M to 3.10B, an increase of 5,092.92%. That is a compound annual growth rate of 26.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 3.00B | 26.07% |
Dec 31, 2024 | 2.38B | 38.84% |
Dec 31, 2023 | 1.72B | 18.27% |
Dec 29, 2022 | 1.45B | -61.93% |
Dec 30, 2021 | 3.81B | 35.22% |
Dec 31, 2020 | 2.82B | 65.90% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 76.28B |
Kamada | 1.33B |
Bait Bakfar | 974.87M |
BrainsWay | 959.64M |
SofWave Medical | 943.38M |
Ilex Medical | 747.81M |
Novolog (Pharm-Up 1966) | 661.07M |
Bonus BioGroup | 274.46M |